Pharmacotherapeutic strategies using small molecules for the treatment of glycolipid lysosomal storage disorders

This publication has 53 references indexed in Scilit:

• Effective cell and gene therapy in a murine model of Gaucher disease
  Proceedings of the National Academy of Sciences, 2006
• Effective gene therapy in an authentic model of Tay-Sachs-related diseases
  Proceedings of the National Academy of Sciences, 2006
• Lysosomal storage diseases: Natural history and ethical and economic aspects
  Molecular Genetics and Metabolism, 2006
• AAV8‐mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease
  The Journal of Gene Medicine, 2006
• Reversion of the biochemical defects in murine embryonic Sandhoff neurons using a bicistronic lentiviral vector encoding hexosaminidase α and β
  Journal of Neurochemistry, 2006
• A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay–Sachs disease
  Human Molecular Genetics, 2005
• Bicistronic lentiviral vector corrects β-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts
  Neurobiology of Disease, 2005
• β-hexosaminidase lentiviral vectors: transfer into the CNS via systemic administration
  Molecular Brain Research, 2005
• Lysosomal storage disorders
  British Journal of Haematology, 2005
• Retrovirus-mediated enzymatic correction of Tay-Sachs defect in transduced and non-transduced cells
  Human Molecular Genetics, 1998